ATE273002T1 - Feste lösung eines fungizids mit erhöhter bioverfügbarkeit - Google Patents

Feste lösung eines fungizids mit erhöhter bioverfügbarkeit

Info

Publication number
ATE273002T1
ATE273002T1 AT97931119T AT97931119T ATE273002T1 AT E273002 T1 ATE273002 T1 AT E273002T1 AT 97931119 T AT97931119 T AT 97931119T AT 97931119 T AT97931119 T AT 97931119T AT E273002 T1 ATE273002 T1 AT E273002T1
Authority
AT
Austria
Prior art keywords
solid solution
fungicide
increased bioavailability
formula
compound
Prior art date
Application number
AT97931119T
Other languages
English (en)
Inventor
Surendra A Sangekar
Ping I Lee
Winston A Vadino
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE273002T1 publication Critical patent/ATE273002T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97931119T 1996-06-28 1997-06-25 Feste lösung eines fungizids mit erhöhter bioverfügbarkeit ATE273002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67270696A 1996-06-28 1996-06-28
PCT/US1997/010120 WO1998000113A1 (en) 1996-06-28 1997-06-25 Solid solution of an antifungal agent with enhanced bioavailability

Publications (1)

Publication Number Publication Date
ATE273002T1 true ATE273002T1 (de) 2004-08-15

Family

ID=24699673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97931119T ATE273002T1 (de) 1996-06-28 1997-06-25 Feste lösung eines fungizids mit erhöhter bioverfügbarkeit

Country Status (7)

Country Link
EP (1) EP0954288B1 (de)
JP (1) JP2000514057A (de)
AT (1) ATE273002T1 (de)
AU (1) AU3483497A (de)
DE (1) DE69730241T2 (de)
ES (1) ES2224256T3 (de)
WO (1) WO1998000113A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
BR9813728A (pt) * 1997-12-22 2000-10-10 Schering Corp Composição de dispersão molecular com elevada biodisponibilidade
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6316462B1 (en) * 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
EP1239831B1 (de) 1999-12-23 2012-10-31 Mayne Pharma International Pty Ltd. Verbesserte pharmazeutische zusammensetzungen für schwerlösliche arzneistoffe
GB0019296D0 (en) * 2000-08-07 2000-09-27 Nipa Lab Limited Treatment for part processed leather
ITMI20022748A1 (it) 2002-12-23 2004-06-24 Eurand Int Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione.
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
KR20200065093A (ko) 2012-06-21 2020-06-08 메인 파마 인터내셔널 프로프라이어터리 리미티드 이트라코나졸 조성물 및 투여형, 그리고 이것들의 사용 방법
ES3063790T3 (en) 2015-06-09 2026-04-20 Lonza Sales Ag Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
PL3331501T3 (pl) 2015-08-08 2020-03-31 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Preparat o zwiększonej odporności na warunki przewodu pokarmowego zawierający pozakonazol
EP4424308A3 (de) 2016-02-26 2024-12-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Magenresistente formulierung mit posaconazol und einem polymeren fällungshemmer
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
US10702520B1 (en) 2019-01-29 2020-07-07 Slayback Pharma Llc Pharmaceutical compositions of posaconazole
WO2022034232A1 (en) 2020-08-13 2022-02-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant high-strength formulation containing posaconazole
EP4181883B1 (de) 2021-11-25 2025-11-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Posaconazol-haltige granulate
EP4091604B1 (de) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Posaconazol-haltige granulate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617612B1 (de) * 1991-12-18 1997-09-10 Warner-Lambert Company Verfahren für die herstellung einer festen dispersion
IL112081A (en) * 1993-12-21 2001-08-26 Schering Plough Corp Tetrahydrofuran derivatives, their preparation and antifungal pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69730241D1 (de) 2004-09-16
EP0954288A1 (de) 1999-11-10
EP0954288B1 (de) 2004-08-11
ES2224256T3 (es) 2005-03-01
JP2000514057A (ja) 2000-10-24
AU3483497A (en) 1998-01-21
DE69730241T2 (de) 2005-08-11
WO1998000113A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
DE69730241D1 (de) Feste lösung eines fungizids mit erhöhter bioverfügbarkeit
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
NL300219I1 (nl) Tetrahydrofuran antischimmelmiddelen.
MX9200875A (es) Compuestos de fluoroalquenilo y su uso como repelentes de pestes.
TR199902611A2 (xx) �nsektisit ve akarasit �zellikleri g�steren etken bile�ik kombinasyonlar�.
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
NO924172D0 (no) Substituerte bifenylpyridoner
CA2098256A1 (en) Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
ATE63220T1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
FR2677982B1 (fr) Composes polyfluoroalkylthiopoly(ethylimidazolium), procede de preparation et leur utilisation comme agents biocides.
EA199900935A1 (ru) Соединения индазоламида в качестве серотонинергических агентов
FI852806L (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
DK0714387T3 (da) Hidtil ukendte bis-naphthalimider til behandling af cancer
FR2680367B1 (fr) Phosphite de 4-piperidyle methyle a l'azote et son application comme stabilisant pour matieres organiques.
AU576595B2 (en) Aqueous aerosol coating compositions
EP0546177A4 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
DE69629474D1 (de) Antifungale tetrahydrofurane
CA2258679A1 (en) Solid solution of an antifungal agent with enhanced bioavailability
ATE302757T1 (de) Neue polyzyklische indanylimidazole mit alpha2 adrenergik aktivität
FI905930A7 (fi) Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi
WO1995006473A3 (en) Medical use of polysulfonic acid compound
JPS5643234A (en) Trihaloallyl derivative, and antifungal, preservative and miticidal agent containing said derivative as effective component
JPS55115889A (en) 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties